{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T15:51:25Z","timestamp":1794844285375,"version":"4.9.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Tianjin Municipa Science and Technology Bureau Major Projects","award":["21ZXGWSY00070"],"award-info":[{"award-number":["21ZXGWSY00070"]}]},{"name":"Xinjiang Uygur Autonomous Region Science Foundation Project","award":["2022D01A27"],"award-info":[{"award-number":["2022D01A27"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-025-05635-3","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:14:46Z","timestamp":1744416886000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Butyrate inhibits histone deacetylase 2 expression to alleviate liver fibrosis in biliary atresia"],"prefix":"10.1186","volume":"25","author":[{"given":"Yilin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayinaxi","family":"Musha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghua","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,12]]},"reference":[{"issue":"1","key":"5635_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-024-00533-x","volume":"10","author":"PKH Tam","year":"2024","unstructured":"Tam PKH, Wells RG, Tang CSM, Lui VCH, Hukkinen M, Luque CD, et al. Biliary Atresia. Nat Rev Dis Primers. 2024;10(1):47.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"5635_CR2","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/hep.29905","volume":"68","author":"JA Bezerra","year":"2018","unstructured":"Bezerra JA, Wells RG, Mack CL, Karpen SJ, Hoofnagle JH, Doo E, et al. Biliary Atresia: clinical and research challenges for the Twenty-First century. Hepatology. 2018;68(3):1163\u201373.","journal-title":"Hepatology"},{"issue":"9702","key":"5635_CR3","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/S0140-6736(09)60946-6","volume":"374","author":"JL Hartley","year":"2009","unstructured":"Hartley JL, Davenport M, Kelly DA. Biliary Atresia. Lancet. 2009;374(9702):1704\u201313.","journal-title":"Lancet"},{"issue":"6","key":"5635_CR4","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrgastro.2015.74","volume":"12","author":"A Asai","year":"2015","unstructured":"Asai A, Miethke A, Bezerra JA. Pathogenesis of biliary Atresia: defining biology to understand clinical phenotypes. Nat Reviews Gastroenterol Hepatol. 2015;12(6):342\u201352.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"10","key":"5635_CR5","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.jpedsurg.2015.03.001","volume":"50","author":"A Zani","year":"2015","unstructured":"Zani A, Quaglia A, Hadzi\u0107 N, Zuckerman M, Davenport M. Cytomegalovirus-associated biliary Atresia: an aetiological and prognostic subgroup. J Pediatr Surg. 2015;50(10):1739\u201345.","journal-title":"J Pediatr Surg"},{"key":"5635_CR6","doi-asserted-by":"crossref","unstructured":"Ortiz-Perez A, Donnelly B, Temple H, Tiao G, Bansal R, Mohanty SK. Innate immunity and pathogenesis of biliary Atresia. Front Immunol. 2020;11.","DOI":"10.3389\/fimmu.2020.00329"},{"issue":"3","key":"5635_CR7","first-page":"281","volume":"61","author":"GB Soomro","year":"2011","unstructured":"Soomro GB, Abbas Z, Hassan M, Luck N, Memon Y, Khan AW. Is there any association of extra hepatic biliary Atresia with cytomegalovirus or other infections? J Pak Med Assoc. 2011;61(3):281\u20133.","journal-title":"J Pak Med Assoc"},{"issue":"12","key":"5635_CR8","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1007\/s00383-017-4173-5","volume":"33","author":"M Kasahara","year":"2017","unstructured":"Kasahara M, Umeshita K, Sakamoto S, Fukuda A, Furukawa H, Uemoto S. Liver transplantation for biliary Atresia: a systematic review. Pediatr Surg Int. 2017;33(12):1289\u201395.","journal-title":"Pediatr Surg Int"},{"issue":"2","key":"5635_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1055\/s-0037-1602763","volume":"37","author":"BC Davis","year":"2017","unstructured":"Davis BC, Bajaj JS. The human gut Microbiome in liver diseases. Semin Liver Dis. 2017;37(2):128\u201340.","journal-title":"Semin Liver Dis"},{"issue":"8","key":"5635_CR10","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1080\/00325481.2015.1098519","volume":"127","author":"DS Bell","year":"2015","unstructured":"Bell DS. Changes seen in gut bacteria content and distribution with obesity: causation or association? Postgrad Med. 2015;127(8):863\u20138.","journal-title":"Postgrad Med"},{"issue":"5","key":"5635_CR11","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.jhep.2017.05.007","volume":"67","author":"R Wiest","year":"2017","unstructured":"Wiest R, Albillos A, Trauner M, Bajaj JS, Jalan R. Targeting the gut-liver axis in liver disease. J Hepatol. 2017;67(5):1084\u2013103.","journal-title":"J Hepatol"},{"issue":"2","key":"5635_CR12","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/jgh.14777","volume":"35","author":"J Wang","year":"2020","unstructured":"Wang J, Qian T, Jiang J, Yang Y, Shen Z, Huang Y, et al. Gut microbial profile in biliary Atresia: a case-control study. J Gastroenterol Hepatol. 2020;35(2):334\u201342.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"5635_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s00383-023-05606-8","volume":"40","author":"X Xu","year":"2023","unstructured":"Xu X, Zhao Y, Wang X, Zhang R, Liu S, Sun R, et al. Diagnostic and prognostic value of the gut microbiota and its metabolite butyrate in children with biliary Atresia. Pediatr Surg Int. 2023;40(1):24.","journal-title":"Pediatr Surg Int"},{"issue":"3","key":"5635_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/embo-reports\/kvf053","volume":"3","author":"A Eberharter","year":"2002","unstructured":"Eberharter A, Becker PB. Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics. EMBO Rep. 2002;3(3):224\u20139.","journal-title":"EMBO Rep"},{"key":"5635_CR15","doi-asserted-by":"crossref","unstructured":"Claveria-Cabello A, Colyn L, Arechederra M, Urman JM, Berasain C, Avila MA et al. Epigenetics Liver Fibrosis: Could HDACs Be Therapeutic Target? Cells. 2020;9(10).","DOI":"10.3390\/cells9102321"},{"issue":"6116","key":"5635_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1126\/science.1227166","volume":"339","author":"T Shimazu","year":"2013","unstructured":"Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, et al. Suppression of oxidative stress by \u03b2-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science. 2013;339(6116):211\u20134.","journal-title":"Science"},{"key":"5635_CR17","doi-asserted-by":"crossref","unstructured":"Gart E, van Duyvenvoorde W, Toet K, Caspers MPM, Verschuren L, Nielsen MJ et al. Butyrate protects against Diet-Induced NASH and liver fibrosis and suppresses specific Non-Canonical TGF-\u03b2 signaling pathways in human hepatic stellate cells. Biomedicines. 2021;9(12).","DOI":"10.3390\/biomedicines9121954"},{"issue":"10","key":"5635_CR18","first-page":"874","volume":"44","author":"XD Xu","year":"2023","unstructured":"Xu XD, Wang XT, Liu SW, Zhao YL, Li MD, Zhao L, et al. Relationship between HDAC2 expression score and progression and prognosis of liver fibrosis in biliary Atresia. Chin J Pediatr Surg. 2023;44(10):874\u201381.","journal-title":"Chin J Pediatr Surg"},{"key":"5635_CR19","doi-asserted-by":"crossref","unstructured":"Barcena-Varela M, Colyn L, Fernandez-Barrena MG. Epigenetic mechanisms in hepatic stellate cell activation during liver fibrosis and carcinogenesis. Int J Mol Sci. 2019;20(10).","DOI":"10.3390\/ijms20102507"},{"issue":"7","key":"5635_CR20","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1872-034X.2011.00804.x","volume":"41","author":"H Tsukamoto","year":"2011","unstructured":"Tsukamoto H, Zhu NL, Asahina K, Mann DA, Mann J. Epigenetic cell fate regulation of hepatic stellate cells. Hepatol Res. 2011;41(7):675\u201382.","journal-title":"Hepatol Res"},{"key":"5635_CR21","doi-asserted-by":"crossref","unstructured":"Liu YR, Wang JQ, Huang ZG, Chen RN, Cao X, Zhu DC et al. Histone deacetylase\u20132: A potential regulator and therapeutic target in liver disease (Review). Int J Mol Med. 2021;48(1).","DOI":"10.3892\/ijmm.2021.4964"},{"issue":"2","key":"5635_CR22","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1002\/jcp.26078","volume":"233","author":"S Jahan","year":"2018","unstructured":"Jahan S, Sun JM, He S, Davie JR. Transcription-dependent association of HDAC2 with active chromatin. J Cell Physiol. 2018;233(2):1650\u20137.","journal-title":"J Cell Physiol"},{"issue":"12","key":"5635_CR23","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.tips.2009.09.007","volume":"30","author":"OH Kr\u00e4mer","year":"2009","unstructured":"Kr\u00e4mer OH. HDAC2: a critical factor in health and disease. Trends Pharmacol Sci. 2009;30(12):647\u201355.","journal-title":"Trends Pharmacol Sci"},{"key":"5635_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.taap.2016.07.003","volume":"306","author":"X Li","year":"2016","unstructured":"Li X, Wu XQ, Xu T, Li XF, Yang Y, Li WX, et al. Role of histone deacetylases(HDACs) in progression and reversal of liver fibrosis. Toxicol Appl Pharmacol. 2016;306:58\u201368.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"12","key":"5635_CR25","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1111\/obr.12068","volume":"14","author":"LK Brahe","year":"2013","unstructured":"Brahe LK, Astrup A, Larsen LH. Is butyrate the link between diet, intestinal microbiota and obesity-related metabolic diseases? Obes Rev. 2013;14(12):950\u20139.","journal-title":"Obes Rev"},{"key":"5635_CR26","doi-asserted-by":"publisher","first-page":"115943","DOI":"10.1016\/j.ecoenv.2024.115943","volume":"270","author":"J Tang","year":"2024","unstructured":"Tang J, Zhao H, Li K, Zhou H, Chen Q, Wang H, et al. Intestinal microbiota promoted NiONPs-induced liver fibrosis via effecting serum metabolism. Ecotoxicol Environ Saf. 2024;270:115943.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"4","key":"5635_CR27","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1053\/j.gastro.2024.05.014","volume":"167","author":"R Wang","year":"2024","unstructured":"Wang R, Li B, Huang B, Li Y, Liu Q, Lyu Z, et al. Gut Microbiota-Derived butyrate induces epigenetic and metabolic reprogramming in Myeloid-Derived suppressor cells to alleviate primary biliary cholangitis. Gastroenterology. 2024;167(4):733\u2013e493.","journal-title":"Gastroenterology"},{"key":"5635_CR28","doi-asserted-by":"publisher","first-page":"1422770","DOI":"10.3389\/fphar.2024.1422770","volume":"15","author":"J Yang","year":"2024","unstructured":"Yang J, Chen L, Zhao SS, Du C, Fan YZ, Liu HX, et al. FGF21-dependent alleviation of cholestasis-induced liver fibrosis by sodium butyrate. Front Pharmacol. 2024;15:1422770.","journal-title":"Front Pharmacol"},{"issue":"1","key":"5635_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3748\/wjg.v23.i1.60","volume":"23","author":"D Zhou","year":"2017","unstructured":"Zhou D, Pan Q, Xin FZ, Zhang RN, He CX, Chen GY, et al. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and Gastrointestinal barrier. World J Gastroenterol. 2017;23(1):60\u201375.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"5635_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/advances\/nmx009","volume":"9","author":"H Liu","year":"2018","unstructured":"Liu H, Wang J, He T, Becker S, Zhang G, Li D, et al. Butyrate: A Double-Edged sword for health?? Adv Nutr. 2018;9(1):21\u20139.","journal-title":"Adv Nutr"},{"issue":"4","key":"5635_CR31","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.molcel.2012.08.033","volume":"48","author":"DR Donohoe","year":"2012","unstructured":"Donohoe DR, Collins LB, Wali A, Bigler R, Sun W, Bultman SJ. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol Cell. 2012;48(4):612\u201326.","journal-title":"Mol Cell"},{"issue":"4","key":"5635_CR32","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1499-3872(17)60019-5","volume":"16","author":"F Shen","year":"2017","unstructured":"Shen F, Zheng RD, Sun XQ, Ding WJ, Wang XY, Fan JG. Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease. Hepatobiliary Pancreat Dis Int. 2017;16(4):375\u201381.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"12","key":"5635_CR33","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1007\/s00383-022-05258-0","volume":"38","author":"K Zhang","year":"2022","unstructured":"Zhang K, Chen Y, Zheng Z, Tang C, Zhu D, Xia X, et al. Relationship between the expression levels of CD4\u2009+\u2009T cells, IL-6, IL-8 and IL-33 in the liver of biliary Atresia and postoperative cholangitis, operative age and early jaundice clearance. Pediatr Surg Int. 2022;38(12):1939\u201347.","journal-title":"Pediatr Surg Int"},{"key":"5635_CR34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fphys.2012.00069","volume":"3","author":"X Kong","year":"2012","unstructured":"Kong X, Horiguchi N, Mori M, Gao B. Cytokines and stats in liver fibrosis. Front Physiol. 2012;3:69.","journal-title":"Front Physiol"},{"issue":"2","key":"5635_CR35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s13668-023-00461-4","volume":"12","author":"O Mohamed Elfadil","year":"2023","unstructured":"Mohamed Elfadil O, Mundi MS, Abdelmagid MG, Patel A, Patel N, Martindale R. Butyrate: more than a short chain fatty acid. Curr Nutr Rep. 2023;12(2):255\u201362.","journal-title":"Curr Nutr Rep"},{"issue":"1","key":"5635_CR36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/lipd.12005","volume":"53","author":"H Yu","year":"2018","unstructured":"Yu H, Li R, Huang H, Yao R, Shen S. Short-Chain fatty acids enhance the lipid accumulation of 3T3-L1 cells by modulating the expression of enzymes of fatty acid metabolism. Lipids. 2018;53(1):77\u201384.","journal-title":"Lipids"},{"issue":"7","key":"5635_CR37","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.cell.2016.05.018","volume":"165","author":"GE Kaiko","year":"2016","unstructured":"Kaiko GE, Ryu SH, Koues OI, Collins PL, Solnica-Krezel L, Pearce EJ, et al. The colonic crypt protects stem cells from Microbiota-Derived metabolites. Cell. 2016;165(7):1708\u201320.","journal-title":"Cell"},{"key":"5635_CR38","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3389\/fimmu.2017.01036","volume":"8","author":"M Kespohl","year":"2017","unstructured":"Kespohl M, Vachharajani N, Luu M, Harb H, Pautz S, Wolff S, et al. The microbial metabolite butyrate induces expression of Th1-Associated factors in CD4(+) T cells. Front Immunol. 2017;8:1036.","journal-title":"Front Immunol"},{"key":"5635_CR39","doi-asserted-by":"crossref","unstructured":"Li J, Mu Y, Liu Y, Kishimura A, Mori T, Katayama Y. Effect of size and loading of retinoic acid in Polyvinyl butyrate nanoparticles on amelioration of colitis. Polym (Basel). 2021;13(9).","DOI":"10.3390\/polym13091472"},{"issue":"17","key":"5635_CR40","doi-asserted-by":"publisher","first-page":"17849","DOI":"10.1002\/cam4.6416","volume":"12","author":"K Nouso","year":"2023","unstructured":"Nouso K, Shiota S, Fujita R, Wakuta A, Kariyama K, Hiraoka A, et al. Effect of butyrate-producing Enterobacteria on advanced hepatocellular carcinoma treatment with Atezolizumab and bevacizumab. Cancer Med. 2023;12(17):17849\u201355.","journal-title":"Cancer Med"},{"issue":"12","key":"5635_CR41","doi-asserted-by":"publisher","first-page":"e2244912","DOI":"10.1001\/jamanetworkopen.2022.44912","volume":"5","author":"S Coppola","year":"2022","unstructured":"Coppola S, Nocerino R, Paparo L, Bedogni G, Calignano A, Di Scala C, et al. Therapeutic effects of butyrate on pediatric obesity: A randomized clinical trial. JAMA Netw Open. 2022;5(12):e2244912.","journal-title":"JAMA Netw Open"},{"key":"5635_CR42","doi-asserted-by":"crossref","unstructured":"Pietrzak A, Banasiuk M, Szczepanik M, Borys-Iwanicka A, Pytrus T, Walkowiak J et al. Sodium butyrate effectiveness in children and adolescents with newly diagnosed inflammatory bowel Diseases-Randomized Placebo-Controlled multicenter trial. Nutrients. 2022;14(16).","DOI":"10.3390\/nu14163283"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05635-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-025-05635-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05635-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T16:55:25Z","timestamp":1744476925000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-025-05635-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,12]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5635"],"URL":"https:\/\/doi.org\/10.1186\/s12887-025-05635-3","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,12]]},"assertion":[{"value":"27 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the declaration of Helsinki. Informed consent was obtained from all subjects and\/or their legal guardian(s). Approval for the research protocol was obtained from the Ethical Committee (2022-SYYJCYJ-008).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"286"}}